ZBIO CIK: 1953926

Zenas BioPharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
59.8
FY24:
356
FY25:
351
(positive)
Change from FY23 to FY25
millions USD
FY23:
8.38
FY24:
14.0
FY25:
32.5
Total assets
Change from FY23 to FY25
millions USD
FY23:
68.2
FY24:
370
FY25:
384

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
23.3
FY24:
57.3
FY25:
62.6
(negative)
Change from FY23 to FY25
millions USD
FY23:
20.6
FY24:
0.22
FY25:
78.8
(positive)
Change from FY23 to FY25
millions USD
FY23:
−226
FY24:
312
FY25:
242
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
370
FY25:
384

All amounts in millions USD Data source:SEC EDGAR